Yersinia Research Unit, Institut Pasteur, Reference Laboratory and World Health Organization Collaborating Centre for Yersinia, Paris, France.
Clin Infect Dis. 2011 Sep;53(6):583-91. doi: 10.1093/cid/cir452.
Bacterial sepsis has become the most frequent infectious complication of transfusion. Although Yersinia enterocolitica is a common enteropathogen usually causing relatively mild disease, it is nevertheless a prominent cause of life-threatening post-transfusion infection. To gain a better understanding of the clinical presentation and prognosis of this rare occurrence, we performed a systematic and detailed review of 55 published cases, which we present here after a description of the mechanisms underlying the contamination of red blood cell preparations by Y. enterocolitica. The symptoms are rapid-onset septic shock sometimes heralded by atypical symptoms, such as explosive diarrhea, with an overall fatality rate of 54.5%. Although the pathophysiology involves transfusion of preformed bacterial endotoxin, timely administration of effective antibiotics seems to improve the prognosis. Increased vigilance of the blood supply could help mitigate this transfusion hazard, although cost-effective strategies are difficult to define for this highly serious but infrequent event.
细菌败血症已成为输血后最常见的感染性并发症。虽然小肠结肠炎耶尔森菌是一种常见的肠道病原体,通常引起相对较轻的疾病,但它仍是导致危及生命的输血后感染的一个突出原因。为了更好地了解这种罕见情况的临床表现和预后,我们对 55 例已发表的病例进行了系统和详细的回顾,在此之后,我们将描述小肠结肠炎耶尔森菌污染红细胞制剂的机制。其症状为迅速发作的感染性休克,有时伴有非典型症状,如暴发性腹泻,总死亡率为 54.5%。虽然发病机制涉及输注预先形成的细菌内毒素,但及时给予有效的抗生素似乎可以改善预后。增加对血液供应的警惕性可能有助于减轻这种输血危害,尽管对于这种非常严重但罕见的事件,难以确定具有成本效益的策略。